The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Management of psoriasis as a systemic disease: what is the evidence?
Open accessAbstract
BACKGROUND: Psoriasis is a chronic, systemic immune-mediated disease characterized by development of erythematous, indurated, scaly, pruritic and often painful skin plaques. Psoriasis pathogenesis is driven by proinflammatory cytokines and psoriasis is associated with increased risk for comorbidities, including, but not limited to, psoriatic arthritis, cardiovascular disease, diabetes mellitus, obesity, inflammatory bowel disease and nonalcoholic fatty liver disease compared with the general population. OBJECTIVES: To explore the pathophysiological relationship between psoriasis and its common comorbidities and discuss the need for new treatment paradigms that include strategies to reduce systemic inflammation in patients with moderate-to-severe psoriasis. METHODS: This narrative review summarizes the published evidence related to the ability of biological therapies to ameliorate the consequences of systemic inflammation in patients with psoriasis. RESULTS: Current evidence suggests that preventing damage associated with inflammation, and preventing development of future inflammatory damage and comorbidities, may be a potentially achievable treatment goal for many patients with moderate-to-severe plaque psoriasis when biological therapies are utilized early in the disease. Encouraging data from recent studies suggest that the loftier goal of reversing existing inflammatory damage and improving signs and symptoms of inflammatory comorbidities could also possibly be attainable. CONCLUSIONS: Results from ongoing prospective studies regarding the effects of biologics on markers of systemic inflammation in patients with psoriasis will strengthen the clinical evidence base that can be used to inform treatment decisions for patients with moderate-to-severe psoriasis. What's already known about this topic? Psoriasis is a systemic inflammatory disease and treatments are needed to optimize patient outcomes. What does this study add? This review discusses new psoriasis treatment paradigms that may potentially reduce effects of systemic inflammation. Evidence demonstrating that biological treatment may prevent or reverse inflammatory damage associated with psoriasis comorbidities is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Pathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Di Cesare, A., Di Meglio, P., & Nestle, F. O. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.59 · Cited by 1,129
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
Sherlock, J. P., Joyce-Shaikh, B., Turner, S. P., Chao, C.-C., Sathe, M., Grein, J., Gorman, D. M., Bowman, E. P., McClanahan, T. K., Yearley, J. H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2817 · Cited by 1,060
Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206624 · Cited by 907
Arican, O., Aral, M., Sasmaz, S., & Ciragil, P. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.273 · Cited by 805
Psoriasis prevalence among adults in the United States
Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.013 · Cited by 783
Assessment of Left Ventricular Function by Echocardiography
Potter, E., & Marwick, T. H. (2018) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.11.017 · Cited by 737
Davidovici, B. B., Sattar, N., Jörg, P. C., Puig, L., Emery, P., Barker, J. N., van de Kerkhof, P., Ståhle, M., Nestle, F. O., Girolomoni, G., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.103 · Cited by 711
Baeten, D., Baraliakos, X., Braun, J., Sieper, J., Emery, P., van der Heijde, D., McInnes, I., van Laar, J. M., Landewé, R., Wordsworth, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61134-4 · Cited by 595
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2012) · Nutrition & Diabetes · doi:10.1038/nutd.2012.26 · Cited by 514
Mease, P. J., Gladman, D. D., Papp, K. A., Khraishi, M. M., Thaçi, D., Behrens, F., Northington, R., Fuiman, J., Bananis, E., Boggs, R., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.07.023 · Cited by 508
Psoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study
Yeung, H., Takeshita, J., Mehta, N. N., Kimmel, S. E., Ogdie, A., Margolis, D. J., Shin, D. B., Attor, R., Troxel, A. B., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5015 · Cited by 464
Obesity predisposes to Th17 bias
Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., & Dosch, H. ‐. (2009) · European Journal of Immunology · doi:10.1002/eji.200838893 · Cited by 377
Baliwag, J., Barnes, D. H., & Johnston, A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.014 · Cited by 373
The concept of psoriasis as a systemic inflammation: implications for disease management
Reich, K. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04410.x · Cited by 360
McInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202646 · Cited by 343
C-reactive protein, inflammation and coronary heart disease
Shrivastava, A. K., Singh, H. V., Raizada, A., & Singh, S. K. (2015) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2014.11.005 · Cited by 320
Suárez-Fariñas, M., Li, K., Fuentes-Duculan, J., Hayden, K., Brodmerkel, C., & Krueger, J. G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.184 · Cited by 305
Wu, J. J., Poon, K.-Y. T., Channual, J. C., & Shen, A. Y.-J. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2502 · Cited by 304
β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice
Ruutu, M., Thomas, G., Steck, R., Degli‐Esposti, M. A., Zinkernagel, M. S., Alexander, K., Velasco, J., Strutton, G., Tran, A., Benham, H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34423 · Cited by 262
Effects of Etanercept in Patients With the Metabolic Syndrome
Bernstein, L. E., Berry, J., Kim, S., Canavan, B., & Grinspoon, S. K. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.8.902 · Cited by 257
Russo, C., Jin, Z., Elkind, M. S. V., Rundek, T., Homma, S., Sacco, R. L., & Di Tullio, M. R. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.154 · Cited by 252
Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1
Endo, Y., Asou, H. K., Matsugae, N., Hirahara, K., Shinoda, K., Tumes, D. J., Tokuyama, H., Yokote, K., & Nakayama, T. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.014 · Cited by 249
Psoriasis patients show signs of insulin resistance
Boehncke, S., Thaci, D., Beschmann, H., Ludwig, R. J., Ackermann, H., Badenhoop, K., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08190.x · Cited by 248
Update on psoriasis immunopathogenesis and targeted immunotherapy
Mahil, S. K., Capon, F., & Barker, J. N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-015-0539-8 · Cited by 245
β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
Kolbinger, F., Loesche, C., Valentin, M.-A., Jiang, X., Cheng, Y., Jarvis, P., Peters, T., Calonder, C., Bruin, G., Polus, F., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.038 · Cited by 238
Popa, C., Netea, M. G., Radstake, T., Van der Meer, J. W. M., Stalenhoef, A. F. H., van Riel, P. L. C. M., & Barerra, P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023119 · Cited by 224
Mehta, N. N. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.119 · Cited by 223
Benham, H., Rehaume, L. M., Hasnain, S. Z., Velasco, J., Baillet, A. C., Ruutu, M., Kikly, K., Wang, R., Tseng, H., Thomas, G. P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38638 · Cited by 211
IL-17 receptor and its functional significance in psoriatic arthritis
Raychaudhuri, S. P., Raychaudhuri, S. K., & Genovese, M. C. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1036-6 · Cited by 203
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
Strober, B., Teller, C., Yamauchi, P., Miller, J. L., Hooper, M., Yang, Y.-C., & Dann, F. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08628.x · Cited by 200
Ahlehoff, O., Skov, L., Gislason, G., Gniadecki, R., Iversen, L., Bryld, L. E., Lasthein, S., Lindhardsen, J., Kristensen, S. L., Torp‐Pedersen, C., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12768 · Cited by 189
Lerman, J. B., Joshi, A. A., Chaturvedi, A., Aberra, T. M., Dey, A. K., Rodante, J. A., Salahuddin, T., Chung, J. H., Rana, A., Teague, H. L., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026859 · Cited by 174
Gisondi, P., Cotena, C., Tessari, G., & Girolomoni, G. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02429.x · Cited by 171
Candia, R., Ruiz, A., Torres‐Robles, R., Chávez‐Tapia, N., Méndez‐Sánchez, N., & Arrese, M. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12847 · Cited by 165
Butcher, M. J., Gjurich, B. N., Phillips, T., & Galkina, E. V. (2012) · Circulation Research · doi:10.1161/circresaha.111.261784 · Cited by 165
Low, A. S. L., Symmons, D. P. M., Lunt, M., Mercer, L. K., Gale, C. P., Watson, K. D., Dixon, W. G., & Hyrich, K. L. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209784 · Cited by 158
Erbel, C., Akhavanpoor, M., Okuyucu, D., Wangler, S., Dietz, A., Zhao, L., Stellos, K., Little, K. M., Lasitschka, F., Doesch, A. O., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400181 · Cited by 158
Armstrong, A. W., Voyles, S. V., Armstrong, E. J., Fuller, E. N., & Rutledge, J. C. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01308.x · Cited by 157
Mehta, N. N., Shin, D. B., Joshi, A. A., Dey, A. K., Armstrong, A. W., Duffin, K. C., Fuxench, Z. C. C., Harrington, C. L., Hubbard, R. A., Kalb, R. E., et al. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007394 · Cited by 157
Porto, F. D., Laganà, B., Lai, S., Nofroni, I., Tinti, F., Vitale, M., Podestà, E., Mitterhofer, A. P., & D’Amelio, R. (2007) · Rheumatology · doi:10.1093/rheumatology/kem089 · Cited by 156
van Baarsen, L. G. M., Lebre, M. C., van der Coelen, D., Aarrass, S., Tang, M. W., Ramwadhdoebé, T. H., Gerlag, D. M., & Tak, P. P. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0426-z · Cited by 150
Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study
Egeberg, A., Mallbris, L., Warren, R. B., Bachelez, H., Gislason, G., Hansen, P. R., & Skov, L. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14528 · Cited by 150
Strober, B. E., Leonardi, C. L., Papp, K. A., Mrowietz, U., Ohtsuki, M., Bissonnette, R., Ferris, L. K., Paul, C. F., Lebwohl, M., Braun, D. K., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.09.026 · Cited by 130
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis
Joshi, A. A., Lerman, J. B., Aberra, T. M., Afshar, M. S., Teague, H., Rodante, J. A., Krishnamoorthy, P. M., Ng, Q., Aridi, T. G., Salahuddin, T., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309637 · Cited by 130
The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
Abuabara, K., Lee, H., & Kimball, A. B. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10525.x · Cited by 128
Tam, L., Kitas, G. D., & González-Gay, M. Á. (2014) · Rheumatology · doi:10.1093/rheumatology/ket454 · Cited by 123
Progress in Understanding the Immunopathogenesis of Psoriasis
Mak, R. K. H., Hundhausen, C., & Nestle, F. O. (2009) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(09)73372-1 · Cited by 122
Wu, J. J., Guérin, A., Sundaram, M., Dea, K., Cloutier, M., & Mulani, P. M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.042 · Cited by 121
Griffiths, C. E. M., Fava, M., Miller, A. H., Russell, J., Ball, S. G., Xu, W., Acharya, N., & Rapaport, M. H. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000479163 · Cited by 115
Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis
Dey, A. K., Joshi, A. A., Chaturvedi, A., Lerman, J. B., Aberra, T. M., Rodante, J. A., Teague, H., Harrington, C. L., Rivers, J. P., Chung, J. H. N., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.1213 · Cited by 110
Risk Indicators for Inflammatory Bowel Disease
Persson, P.-G., Leijonmarck, C.-E., Bernell, O., Hellers, G., & Ahlbom, A. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.2.268 · Cited by 109
The Relationship of Obesity With the Severity of Psoriasis: A Systematic Review
Fleming, P., Kraft, J. N., Gulliver, W. P. F., & Lynde, C. W. (2015) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475415586332 · Cited by 100
Renzo, L. D., Saraceno, R., Schipani, C., et al. (2011) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2011.01439.x · Cited by 96
Bissonnette, R., Harel, F., Krueger, J. G., Guertin, M., Chabot-Blanchet, M., Gonzalez, J., Maari, C., Delorme, I., Lynde, C. W., & Tardif, J. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.02.977 · Cited by 93
The role of inflammation in heart failure: new therapeutic approaches.
Oikonomou, E. K., Tousoulis, D., Siasos, G., Zaromitidou, M., Papavassiliou, A. G., & Stefanadis, C. (2011) · PubMed · Cited by 91
Relationships between Adipose Tissue and Psoriasis, with or without Arthritis
Toussirot, É., Aubin, F., & Dumoulin, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00368 · Cited by 91
Patients with Refractory Crohnʼs Disease Successfully Treated with Ustekinumab
Harris, K. A., Horst, S., Gadani, A., Nohl, A. J., Annis, K. A., Duley, C., Beaulieu, D. B., Ghazi, L. J., & Schwartz, D. A. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000624 · Cited by 89
Gisondi, P., Lora, V., Bonauguri, C., Russo, A., Lippi, G., & Girolomoni, G. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12118 · Cited by 85
Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis
Raychaudhuri, S. K., Saxena, A., & Raychaudhuri, S. P. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-2961-7 · Cited by 82
Campanati, A., Ganzetti, G., Sario, A. D., Damiani, A., Sandroni, L., de la Rosa, L. E. S., Benedetti, A., & Offidani, A. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0678-9 · Cited by 82
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper
Girolomoni, G., Griffiths, C. E. M., Krueger, J. G., Nestle, F. O., Nicolas, J., Prinz, J. C., Puig, L., Ståhle, M., van de Kerkhof, P. C. M., Allez, M., et al. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2014.880396 · Cited by 75
Psoriasis and New-Onset Diabetes
Khalid, U., Hansen, P. R., Gislason, G., Lindhardsen, J., Kristensen, S. L., Winther, S. A., Skov, L., Torp-Pedersen, C. T., & Ahlehoff, O. (2013) · Diabetes Care · doi:10.2337/dc12-2330 · Cited by 74
Psoriasis and non‐alcoholic fatty liver disease
Wenk, K. S., Arrington, K., & Ehrlich, A. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03841.x · Cited by 74
Pina, T., Armesto, S., López‐Mejías, R., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12814 · Cited by 72
Vadakayil, A., Dandekeri, S., Kambil, S., & Ali, N. (2015) · Indian Dermatology Online Journal · doi:10.4103/2229-5178.164483 · Cited by 71
IL‐17A, IL‐22, IL‐6, and IL‐21 Serum Levels in Plaque‐Type Psoriasis in Brazilian Patients
de Oliveira, P. S. S., Cardoso, P. R. G., Lima, E. V. D. A., Pereira, M. C., Duarte, Â. L. B. P., Pitta, I. D. R., Rêgo, M. J. B. D. M., & Pitta, M. G. D. R. (2015) · Mediators of Inflammation · doi:10.1155/2015/819149 · Cited by 70
Wu, J. J., Sundaram, M., Cloutier, M., Gauthier‐Loiselle, M., Guérin, A., Singh, R., & Ganguli, A. X. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.02.050 · Cited by 68
Swindell, W. R., Johnston, A. W. B., Xing, X., Voorhees, J. J., Elder, J. T., & Gudjonsson, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079253 · Cited by 66
Wu, J. J., Joshi, A. A., Reddy, S. P., Batech, M., Egeberg, A., Ahlehoff, O., & Mehta, N. N. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14951 · Cited by 54
Hjuler, K. F., Gormsen, L. C., Vendelbo, M. H., Egeberg, A., Nielsen, J. S., & Iversen, L. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15149 · Cited by 51
Association between psoriasis and coronary calcium score
Staniak, H. L., Bittencourt, M. S., Santos, I. S., Sharovsky, R., Sabbag, C. Y., Goulart, A. C., Lotufo, P. A., & Benseñor, I. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.11.004 · Cited by 49
Martínez‐López, A., Blasco‐Morente, G., Pérez‐López, I., Tercedor‐Sánchez, J., & Arias‐Santiago, S. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14841 · Cited by 48
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab
Lora, V., Bonaguri, C., Gisondi, P., Sandei, F., Battistelli, L., Russo, A., Melegari, A., Trenti, T., Lippi, G., & Girolomoni, G. (2013) · Immunologic Research · doi:10.1007/s12026-013-8410-2 · Cited by 46
Kim, B., Lee, W., Pak, K., Han, J., Kim, G., Kim, H.-S., Ko, H., Kim, M., & Kim, S. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.03.011 · Cited by 45
Psoriasis, the liver, and the gastrointestinal tract
Gisondi, P., Giglio, M. D., Cozzi, A., & Girolomoni, G. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01310.x · Cited by 44
González‐Cantero, Á., Gonzalez-Calvin, J. L., Sánchez‐Moya, A. I., Pérez‐Hortet, C., Arias‐Santiago, S., Schöendorff‐Ortega, C., & Gonzalez-Calvin, J. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211808 · Cited by 43
Risk of Cardiovascular Disorders in Psoriasis Patients: Current and Future
Tablazon, I. L. D., Al‐Dabagh, A., Davis, S., & Feldman, S. R. (2012) · American Journal of Clinical Dermatology · doi:10.1007/s40257-012-0005-5 · Cited by 37
Ahlehoff, O., Hansen, P. R., Gislason, G., Frydland, M. S., Bryld, L. E., Elming, H., & Jemec, G. B. E. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13152 · Cited by 37
Youn, S. W., Kang, S. Y., Kim, S. A., Park, G. Y., & Lee, W. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12859 · Cited by 35
Montaudié, H., Albert-Sabonnadière, C., Acquacalda, É., Fontas, É., Danré, A., Roux, C. H., Ortonne, J. ‐., Lacour, J. ‐., Euller‐Ziegler, L., & Passeron, T. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12255 · Cited by 33
More than skin-deep: the many dimensions of the psoriatic disease
Boehncke, W., & Boehncke, S. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13968 · Cited by 33
Artrite psoriásica: entidade clínica distinta da psoríase?
Ruiz, D. G., de Azevedo, M. N. L., & Santos, O. L. D. R. (2012) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042012000400012 · Cited by 21
Strober, B. E., Poulin, Y. P., Teller, C. F., Wang, Y., Williams, D., & Goldblum, O. M. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12372 · Cited by 19
Psoriasis and insulin resistance: a review
Fitzgerald, R., Sadlier, M., Connolly, M., & Tobin, A. (2014) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-3-3 · Cited by 7
Cited by
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 427
Interleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 300
Chiang, C.-C., Cheng, W.-J., Korinek, M., Lin, C.-Y., & Hwang, T.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02376 · Cited by 289
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications
Singh, R., Koppu, S., Perche, P. O., & Feldman, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312793 · Cited by 192
Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis
Thye, A. Y.-K., Bah, Y.-R., Law, J. W.-F., Tan, L. T.-H., He, Y.-W., Wong, S.-H., Thurairajasingam, S., Chan, K.-G., Lee, L.-H., & Letchumanan, V. (2022) · Biomedicines · doi:10.3390/biomedicines10051037 · Cited by 156
Metadata
- Authors
- Korman, N. J.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-10-15
- Volume
- 182
- Issue
- 4
- Pages
- 840-848
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2949717647
- Cited by
- 539
- References
- 90
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.